Free Trial
NASDAQ:CLVR

Clever Leaves (CLVR) Stock Price, News & Analysis

Clever Leaves logo

About Clever Leaves Stock (NASDAQ:CLVR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
15 shs
Average Volume
1,746 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clever Leaves and its competitors with MarketBeat's FREE daily newsletter.

CLVR Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
Clever Leaves Holdings Inc.
See More Headlines

CLVR Stock Analysis - Frequently Asked Questions

Clever Leaves shares reverse split before market open on Friday, August 25th 2023.The 1-30 reverse split was announced on Thursday, August 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of CLVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clever Leaves investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Advanced Micro Devices (AMD) and Salesforce (CRM).

Company Calendar

Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CLVR
CIK
1819615
Fax
N/A
Employees
560
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$17.42 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$14.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,755,000
Free Float
1,611,000
Market Cap
N/A
Optionable
No Data
Beta
3,440.04
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:CLVR) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners